Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2022) on “Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]”. NACI recommendations for use of the plant-based virus-like particle COVID-19 vaccine Medicago: Methods, epidemiology, vaccine characteristics, clinical trial data, administration, safety, adverse events and more.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.